- IN₹130.27bn
- IN₹114.52bn
- IN₹28.39bn
- 91
- 17
- 55
- 57
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 25.67 | ||
| PEG Ratio (f) | 1.87 | ||
| EPS Growth (f) | 15.93% | ||
| Dividend Yield (f) | 0.62% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.98 | ||
| Price to Tang. Book | 6.28 | ||
| Price to Free Cashflow | 31.63 | ||
| Price to Sales | 4.46 | ||
| EV to EBITDA | 20.42 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 17.35% | ||
| Return on Equity | 21.53% | ||
| Operating Margin | 16.38% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 9,662.74 | 16,646.09 | 23,061.33 | 25,896 | 28,393 | 32,183.61 | 36,730.28 | 34.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +110.31 | +12.24 | +34.07 | +34.05 | +11.6 | +17.46 | +14.86 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.
Directors
- Last Annual
- March 31st, 2025
- Last Interim
- June 30th, 2025
- Incorporated
- October 16th, 1998
- Public Since
- May 13th, 2024
- No. of Employees
- 4,141
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
National Stock Exchange of India- Shares in Issue
- 240,069,661
- Address
- BANGALORE, 560045
- Web
- https://www.indegene.com/
- Phone
- +91 8046744567
- Contact
- Praveen Hegde
- Auditors
- BSR & Co. LLP
Upcoming Events for INDGN
Similar to INDGN
Aarvi Encon
National Stock Exchange of India
Ace Integrated Solutions
National Stock Exchange of India
Addictive Learning Technology
National Stock Exchange of India
Aditya Infotech
National Stock Exchange of India
AGS Transact Technologies
National Stock Exchange of India
FAQ
As of Today at 21:17 UTC, shares in Indegene are trading at IN₹542.65. This share price information is delayed by 15 minutes.
Shares in Indegene last closed at IN₹542.65 and the price had moved by -20.34% over the past 365 days. In terms of relative price strength the Indegene share price has underperformed the S&P BSE 100 Index by -22.32% over the past year.
The overall consensus recommendation for Indegene is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Indegene dividend yield is 0.37% based on the trailing twelve month period.
Last year, Indegene paid a total dividend of IN₹2.00, and it currently has a trailing dividend yield of 0.37%. We do not have any data on when Indegene is to next pay dividends.
We do not have data on when Indegene is to next pay dividends. The historic dividend yield on Indegene shares is currently 0.37%.
To buy shares in Indegene you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹542.65, shares in Indegene had a market capitalisation of IN₹130.27bn.
Here are the trading details for Indegene:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: INDGN
Based on an overall assessment of its quality, value and momentum Indegene is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Indegene is IN₹615.60. That is 13.44% above the last closing price of IN₹542.65.
Analysts covering Indegene currently have a consensus Earnings Per Share (EPS) forecast of IN₹19.54 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Indegene. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -10.65%.
As of the last closing price of IN₹542.65, shares in Indegene were trading -5.68% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Indegene PE ratio based on its reported earnings over the past 12 months is 25.67. The shares last closed at IN₹542.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Indegene's directors